全文获取类型
收费全文 | 11208篇 |
免费 | 630篇 |
国内免费 | 200篇 |
专业分类
耳鼻咽喉 | 79篇 |
儿科学 | 371篇 |
妇产科学 | 127篇 |
基础医学 | 1282篇 |
口腔科学 | 466篇 |
临床医学 | 1040篇 |
内科学 | 2724篇 |
皮肤病学 | 270篇 |
神经病学 | 831篇 |
特种医学 | 832篇 |
外国民族医学 | 1篇 |
外科学 | 1677篇 |
综合类 | 58篇 |
一般理论 | 1篇 |
预防医学 | 587篇 |
眼科学 | 105篇 |
药学 | 533篇 |
中国医学 | 12篇 |
肿瘤学 | 1042篇 |
出版年
2024年 | 32篇 |
2023年 | 140篇 |
2022年 | 226篇 |
2021年 | 443篇 |
2020年 | 215篇 |
2019年 | 338篇 |
2018年 | 416篇 |
2017年 | 265篇 |
2016年 | 287篇 |
2015年 | 319篇 |
2014年 | 406篇 |
2013年 | 496篇 |
2012年 | 672篇 |
2011年 | 755篇 |
2010年 | 468篇 |
2009年 | 439篇 |
2008年 | 635篇 |
2007年 | 659篇 |
2006年 | 596篇 |
2005年 | 607篇 |
2004年 | 515篇 |
2003年 | 465篇 |
2002年 | 381篇 |
2001年 | 178篇 |
2000年 | 159篇 |
1999年 | 140篇 |
1998年 | 164篇 |
1997年 | 163篇 |
1996年 | 158篇 |
1995年 | 108篇 |
1994年 | 99篇 |
1993年 | 102篇 |
1992年 | 67篇 |
1991年 | 73篇 |
1990年 | 65篇 |
1989年 | 87篇 |
1988年 | 74篇 |
1987年 | 82篇 |
1986年 | 60篇 |
1985年 | 70篇 |
1984年 | 40篇 |
1983年 | 39篇 |
1982年 | 43篇 |
1981年 | 29篇 |
1980年 | 41篇 |
1979年 | 23篇 |
1978年 | 21篇 |
1977年 | 32篇 |
1976年 | 30篇 |
1975年 | 29篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
Genotypic versus phenotypic characterization, with respect to beta-lactam susceptibility, of Haemophilus influenzae isolates exhibiting decreased susceptibility to beta-lactam resistance markers 下载免费PDF全文
Sevillano D Giménez MJ Cercenado E Cafini F Gené A Alou L Marco F Martínez-Martínez L Coronel P Aguilar L 《Antimicrobial agents and chemotherapy》2009,53(1):267-270
Among 165 Spanish Haemophilus influenzae isolates with mutations in the ftsI gene (ftsI+) (2005 to 2007), 73% were β-lactamase negative and 26.7% were positive. The proportion of β-lactamase-negative isolates to β-lactamase-positive isolates was 2:1 to 4:1 in general, versus 1:3 in pediatric hospitals. Among 44 β-lactamase-positive strains, 8 strains produced ROB-1 (5 from the pediatric hospital). β-Lactamase-positive ftsI+ strains were phylogenetically closer than were β-lactamase-negative strains. 相似文献
82.
83.
84.
Lorenzo Pistelli MD Giampaolo Vetta MD Antonio Parlavecchio MD Pasquale Crea MD PhD Francesca Parisi MD Michele Magnocavallo MD PhD Rodolfo Caminiti MD Simone Frea MD Alessandro Vairo MD Paolo Desalvo MD Riccardo Faletti MD Marco Gatti MD Giuseppe Dattilo MD Matteo Parollo MD Andrea Di Cori MD Maria Grazia Bongiorni MD Giulia De Santis MD Marco Borgi MD Marco Franzino MD Roberto Licordari MD Giulio Zucchelli MD PhD Giovanni Domenico Della Rocca MD Carla Giustetto MD PhD 《Journal of cardiovascular electrophysiology》2024,35(2):290-300
85.
Raffaella Lucchini Ciro Franzese Suela Vukcaj Giorgio Purrello Denis Panizza Valeria Faccenda Stefano Andreoli Gian Luca Poli Davide Baldaccini Lorenzo Lo Faro Stefano Tomatis Luigi Franco Cazzaniga Marta Scorsetti Stefano Arcangeli 《Current oncology (Toronto, Ont.)》2022,29(12):9349
Background: The aim of this study was to investigate the feasibility of ultrahypofractionated radiotherapy to the prostate bed in patients with biochemical and/or clinical relapse following radical prostatectomy who were enrolled in the prospective, observational, multicentric POPART trial (). Methods: Patients with post-radical prostatectomy PSA levels of ≥0.1–2.0 ng/mL and/or local relapse at PSMA PET/CT or multiparametric MRI were treated with Linac-based SBRT on the prostate bed up to a total dose of 32.5 Gy in five fractions every other day (EQD21.5 = 74.2 Gy). Maximum acute toxicity was assessed using the Common Terminology Criteria for Adverse Events version 5 scale. International Consultation on Incontinence Questionnaire—Short Form (ICIQ-SF) and Prostate Cancer Index Composite for Clinical Practice (EPIC-CP) scores were assessed at baseline and during the follow-up. Results: From April 2021 to June 2022, thirty men with a median age of 72 years (range 55–82) were enrolled in three centers. The median PSA level before RT was 0.30 ng/mL (range 0.18–1.89 ng/mL). At 3 months post-treatment, no GI or ≥2 GU side effects were reported; three patients (10%) experienced Grade 1 GU toxicity. No changes in ICIQ-SF or in the urinary domains of EPIC-CP were observed, while a transient worsening was registered in the bowel domain. At the same time point, all but two patients, who progressed distantly, were found to be biochemically controlled with a median post-treatment PSA level of 0.07 ng/mL (range 0–0.48 ng/mL). Conclusions: Our preliminary findings show that SBRT can be safely extended to the postoperative setting, without an increase in short-term toxicity or a significant decline in QoL. Long-term results are needed to confirm this strategy. NCT04831970相似文献
86.
Claudio Ferdeghini Andrea Mezzetta Felicia DAndrea Christian Silvio Pomelli Lorenzo Guazzelli Luca Guglielmero 《Materials》2022,15(23)
Two couples of dicationic ionic liquids, featuring pyrrolidinium and piperidinium cations and different linker chains, were prepared and characterized. 1,1′-(propane-1,3-diyl)bis(1-methylpyrrolidinium) bromide, 1,1′-(octane-1,8-diyl)bis(1-methylpyrrolidinium) bromide, 1,1′-(propane-1,3-diyl)bis(1-methylpiperidinium) bromide, and 1,1′-(octane-1,8-diyl)bis(1-methylpiperidinium) bromide were synthesized in quantitative yields and high purity and thermally characterized through TGA and DSC analysis. In this study, we propose a preliminary comparative evaluation of the effect of the linker chain length and of the size of the aliphatic ammonium ring on the thermal and solubility properties of bromide dicationic ionic liquids. 相似文献
87.
88.
Simone Beretta Alessandro Versace Gianfranco Fiore Marco Piola Beatrice Martini Vittorio Bigiogera Lorenzo Coppadoro Jacopo Mariani Lorenzo Tinti Silvia Pirovano Laura Monza Davide Carone Matteo Riva Giada Padovano Gilda Galbiati Francesco Santangelo Marco Rasponi Francesco Padelli Isabella Giachetti Domenico Aquino Susanna Diamanti Laura Librizzi Maria Grazia Bruzzone Marco De Curtis Carlo Giussani Erik P. Sganzerla Carlo Ferrarese 《Neurotherapeutics》2022,19(6):1942
Hypothermia is a promising therapeutic strategy for severe vasospasm and other types of non-thrombotic cerebral ischemia, but its clinical application is limited by significant systemic side effects. We aimed to develop an intraventricular device for the controlled cooling of the cerebrospinal fluid, to produce a targeted hypothermia in the affected cerebral hemisphere with a minimal effect on systemic temperature. An intraventricular cooling device (acronym: V-COOL) was developed by in silico modelling, in vitro testing, and in vivo proof-of-concept application in healthy Wistar rats (n = 42). Cerebral cortical temperature, rectal temperature, and intracranial pressure were monitored at increasing flow rate (0.2 to 0.8 mL/min) and duration of application (10 to 60 min). Survival, neurological outcome, and MRI volumetric analysis of the ventricular system were assessed during the first 24 h. The V-COOL prototyping was designed to minimize extra-cranial heat transfer and intra-cranial pressure load. In vivo application of the V-COOL device produced a flow rate-dependent decrease in cerebral cortical temperature, without affecting systemic temperature. The target degree of cerebral cooling (− 3.0 °C) was obtained in 4.48 min at the flow rate of 0.4 mL/min, without significant changes in intracranial pressure. Survival and neurological outcome at 24 h showed no significant difference compared to sham-treated rats. MRI study showed a transient dilation of the ventricular system (+ 38%) in a subset of animals. The V-COOL technology provides an effective, rapid, selective, and safe cerebral cooling to a clinically relevant degree of − 3.0 °C.Supplementary InformationThe online version contains supplementary material available at 10.1007/s13311-022-01302-y. 相似文献
89.
Tobias G. Kllner Anja David Katrin Luck Franziska Beran Grit Kunert Jing-Jiang Zhou Lorenzo Caputi Sarah E. OConnor 《Proceedings of the National Academy of Sciences of the United States of America》2022,119(42)
Iridoid monoterpenes, widely distributed in plants and insects, have many ecological functions. While the biosynthesis of iridoids has been extensively studied in plants, little is known about how insects synthesize these natural products. Here, we elucidated the biosynthesis of the iridoids cis-trans-nepetalactol and cis-trans-nepetalactone in the pea aphid Acyrthosiphon pisum (Harris), where they act as sex pheromones. The exclusive production of iridoids in hind legs of sexual female aphids allowed us to identify iridoid genes by searching for genes specifically expressed in this tissue. Biochemical characterization of candidate enzymes revealed that the iridoid pathway in aphids proceeds through the same sequence of intermediates as described for plants. The six identified aphid enzymes are unrelated to their counterparts in plants, conclusively demonstrating an independent evolution of the entire iridoid pathway in plants and insects. In contrast to the plant pathway, at least three of the aphid iridoid enzymes are likely membrane bound. We demonstrated that a lipid environment facilitates the cyclization of a reactive enol intermediate to the iridoid cyclopentanoid-pyran scaffold in vitro, suggesting that membranes are an essential component of the aphid iridoid pathway. Altogether, our discovery of this complex insect metabolic pathway establishes the genetic and biochemical basis for the formation of iridoid sex pheromones in aphids, and this discovery also serves as a foundation for understanding the convergent evolution of complex metabolic pathways between kingdoms.Iridoids are a class of atypical bicyclic monoterpenoids that are widely distributed in flowering plants, but, notably, are also found in several insect orders, including Coleoptera, Hymenoptera, and Hemiptera (1). Iridoids therefore present an opportunity to compare and contrast the chemical logic of natural product biosynthesis between plants and insects.In plants, iridoids largely act as defensive metabolites or biosynthetic intermediates for other natural products (e.g., monoterpenoid indole alkaloids and isoquinoline alkaloids). The pathway leading to the cyclopentanoid-pyran (iridoid) scaffold was first elucidated in the plant Madagascar periwinkle (Catharanthus roseus) (2–6) and more recently in the two mint species Nepeta mussinii and Nepeta cataria (7–9). Iridoid biosynthesis in plants starts with the condensation of the universal terpene precursors isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) to form geranyl diphosphate (GPP), followed by hydrolysis to geraniol (Fig. 1A). Both reactions take place in the plastids and are catalyzed by trans-isoprenyl diphosphate synthase (IDS) and geraniol synthase (GES), respectively. Hydroxylation of geraniol by geraniol-8-hydroxylase (G8H) leads to 8-hydroxygeraniol, which is further oxidized in two consecutive reaction steps by 8-hydroxygeraniol oxidase (HGO) to 8-oxogeranial. This dialdehyde is then converted to the iridoid nepetalactol by a two-step reduction–cyclization sequence that involves the formation of a highly reactive 8-oxocitronellyl enol/enolate intermediate. Initially, reduction and cyclization of 8-oxogeranial were thought to be controlled by a single enzyme, iridoid synthase (ISY) (3), though later studies showed that ISY likely catalyzes only the NADPH-dependent reduction of 8-oxogeranial to the 8-oxocitronellyl enol/enolate intermediate (8). This intermediate can nonenzymatically cyclize, or, alternatively, the stereoselective cyclization of this intermediate to nepetalactol is enzymatically mediated by nepetalactol-related short-chain dehydrogenase (NEPS) or by major latex protein-like (MLPL) enzymes (8, 9). In C. roseus, nepetalactol is further metabolized to secologanin, which serves as a precursor for the formation of monoterpene indole alkaloids in this plant (10). In Nepeta, a NEPS protein oxidizes nepetalactol to nepetalactone (8), with both the alcohol and lactone released as volatiles.Open in a separate windowFig. 1.The formation of iridoids in plants and aphids. (A) Labeling studies suggest that the biosynthesis of iridoids in the pea aphid A. pisum mimics the biosynthetic pathway in iridoid-producing plants. IPP, isopentenyl diphosphate; DMAPP, dimethylallyl diphosphate; GPP, geranyl diphosphate; IDS, isoprenyl diphosphate synthase; GES, geranyl diphosphate synthase; G8H, geraniol 8-hydroxylase; HGO, 8-hydroxygeraniol oxidoreductase; ISY, iridoid synthase; NEPO, nepetalactol oxidase. (B) Relative expression of mevalonate and putative nepetalactone pathway genes in hind legs and front legs of different sexual stages of A. pisum. Relative expression data are based on RPKM values obtained by RNAseq. f-hl, hind legs of sexual females; f-fl, front legs of sexual females; af-hl, hind legs of asexual females; m-hl, hind legs of males.Insects utilize iridoids as both defense compounds and volatile pheromones, but in terms of biosynthesis, comparatively little is understood about insect-derived iridoids. Biosynthetic insights have been obtained from studies on larvae of chrysomelid leaf beetles, which accumulate the iridoid-related monocyclic dialdehydes chrysomelidial and plagiodial (11). Feeding experiments with isotopically labeled precursors and the discovery of some of the enzymes involved in chrysomelidial formation demonstrated that leaf beetles produce these compounds by a series of chemical reactions similar to those that occur in plants (12–15). Although the enzymatic basis for this pathway has not been completely established, the fact that the known enzymes are unrelated to their counterparts in plants suggests independent evolution of the pathway occurred (14).Cis-trans-nepetalactol and cis-trans-nepetalactone are the major iridoids produced by catnip (N. mussinii) and catmint (N. cataria) (16). These molecules are responsible for the euphoric effect these plants have on cats, but their ecological function is unclear, though they may play roles in mediating interactions with insects (17). Interestingly, cis-trans-nepetalactol and cis-trans-nepetalactone occur also in aphids, which produce these compounds as volatile sex pheromones (18, 19). The pea aphid Acyrthosiphon pisum, for example, has been reported to biosynthesize (1R,4aS,7S,7aR)-cis-trans-nepetalactol and (4aS,7S,7aR)-cis-trans-nepetalactone in glandular structures on the hind legs of sexual female aphids, from where they are released to attract male conspecifics (18, 20). Recent studies with isotopically labeled iridoid precursors suggest that the iridoid pathway in aphids follows the reaction sequence described for plants (21). However, the underlying enzymatic machinery of this pathway is completely unknown.Here, we report the elucidation of the entire iridoid pathway in the pea aphid A. pisum. By searching for genes expressed exclusively in hind legs of sexual female aphids, the site of iridoid production, we could rapidly identify all six biosynthetic genes/enzymes responsible for the conversion of IPP and DMAPP to cis-trans-nepetalactone. The discovery of the insect nepetalactone pathway in its entirety now allows a comparison of the chemical solutions that have evolved for nepetalactone biosynthesis in plants and animals. Although the chemical steps from GPP to nepetalactone are the same in both Nepeta and pea aphids, the enzymes of these pathways have clearly evolved independently. 相似文献
90.
Yousra Kherabi Mathilde Frchet-Jachym Christophe Rioux Yazdan Yazdanpanah Frdric Mchaï Valrie Pourcher Jrme Robert Lorenzo Guglielmetti for the MDR-TB Management Group 《Emerging infectious diseases》2022,28(9):1796
Definitions of resistance in multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB) have been updated. Pre–XDR TB, defined as MDR TB with additional resistance to fluoroquinolones, and XDR TB, with additional resistance to bedaquiline or linezolid, are frequently associated with treatment failure and toxicity. We retrospectively determined the effects of pre-XDR/XDR TB resistance on outcomes and safety of MDR TB treatment in France. The study included 298 patients treated for MDR TB at 3 reference centers during 2006–2019. Of those, 205 (68.8%) cases were fluoroquinolone-susceptible MDR TB and 93 (31.2%) were pre-XDR/XDR TB. Compared with fluoroquinolone-susceptible MDR TB, pre-XDR/XDR TB was associated with more cavitary lung lesions and bilateral disease and required longer treatment. Overall, 202 patients (67.8%) had favorable treatment outcomes, with no significant difference between pre-XDR/XDR TB (67.7%) and fluoroquinolone-susceptible MDR TB (67.8%; p = 0.99). Pre-XDR/XDR TB was not associated with higher risk for serious adverse events. 相似文献